Platelet activating antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514343, 514336, 546280, 546281, 546284, C07D41704, A61K 3144

Patent

active

051497042

ABSTRACT:
Benzoylphenyl derivatives of 2-(3-pyridinyl)-3-alkyl-4-thiazolidinecarboxamide, 2-(3-pyridinyl)-thiazolid-4-ylacetamide, 2-(3-pyridinyl)-4-dithiolanecarboxamide or 2-(3-pyridinyl)dithiolan-4-yl]urea-group are potent inhibitors of PAF and are useful in the treatment of PAF-related disorders including anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellular immunity, parturtition, fetal lung maturation, and cellular differentiation.

REFERENCES:
patent: 4786645 (1988-11-01), Fabre et al.
patent: 4940709 (1990-07-01), Shimazaki et al.
patent: 4948795 (1990-08-01), Mase et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Platelet activating antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Platelet activating antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet activating antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1068527

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.